Back to mobile site

ImmunoGen (IMGN) Reports a Q2 Loss, Updates FY08 Guidance

January 31, 2008 4:32 PM EST Send to a Friend
ImmunoGen, Inc. (Nasdaq: IMGN) reported a Q2 loss of $0.15, in-line with the analyst estimate of ($0.15) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login